Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: the DBCG-IMN study.
Thorsen LB, Thomsen MS, Overgaard M, Overgaard J, Offersen BV; Danish Breast Cancer Cooperative Group Radiotherapy Committee. Thorsen LB, et al. Acta Oncol. 2013 Oct;52(7):1526-34. doi: 10.3109/0284186X.2013.813643. Epub 2013 Aug 19. Acta Oncol. 2013. PMID: 23957621
The prognostic relevance of estimates of proliferative activity in early breast cancer.
Offersen BV, Sørensen FB, Knoop A, Overgaard J; Danish Breast Cancer Cooperative Tumour Biology Committee. Offersen BV, et al. Histopathology. 2003 Dec;43(6):573-82. doi: 10.1111/j.1365-2559.2003.01745.x. Histopathology. 2003. PMID: 14636258
Chalkley estimates of angiogenesis in early breast cancer--relevance to prognosis.
Offersen BV, Sørensen FB, Yilmaz M, Knoop A, Overgaard J; Danish Breast Cancer Cooperative Group Tumour Biology Committee. Offersen BV, et al. Acta Oncol. 2002;41(7-8):695-703. Acta Oncol. 2002. PMID: 14651216
Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis.
Offersen BV, Pfeiffer P, Andreasen P, Overgaard J. Offersen BV, et al. Lung Cancer. 2007 Apr;56(1):43-50. doi: 10.1016/j.lungcan.2006.11.018. Epub 2007 Jan 17. Lung Cancer. 2007. PMID: 17207889
Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer.
Offersen BV, Riisbro R, Knoop A, Brünner N, Overgaard J; Danish Breast Cancer Cooperative Group (DBCG) Tumor Biology Committee. Offersen BV, et al. Acta Oncol. 2007;46(6):782-91. doi: 10.1080/02841860601116383. Acta Oncol. 2007. PMID: 17653901
A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, Overgaard J. Alsner J, et al. Acta Oncol. 2008;47(4):600-7. doi: 10.1080/02841860802047411. Acta Oncol. 2008. PMID: 18465328
A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer.
Offersen BV, Alsner J, Ege Olsen K, Riisbro R, Brünner N, Sørensen FB, Sørensen BS, Schlemmer BO, Overgaard J. Offersen BV, et al. Acta Oncol. 2008;47(4):618-32. doi: 10.1080/02841860801958295. Acta Oncol. 2008. PMID: 18465330
Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review.
Offersen BV, Overgaard M, Kroman N, Overgaard J. Offersen BV, et al. Radiother Oncol. 2009 Jan;90(1):1-13. doi: 10.1016/j.radonc.2008.08.005. Epub 2008 Sep 8. Radiother Oncol. 2009. PMID: 18783840 Review.
Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival.
Offersen BV, Knap MM, Horsman MR, Verheijen J, Hanemaaijer R, Overgaard J. Offersen BV, et al. Acta Oncol. 2010 Nov;49(8):1283-7. doi: 10.3109/0284186X.2010.509109. Epub 2010 Sep 15. Acta Oncol. 2010. PMID: 20843171
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P, Bjerre K, Ejlertsen B, Jensen MB, Rasmussen BB, Lænkholm AV, Kroman N, Ewertz M, Offersen B, Toftdahl DB, Møller S, Mouridsen HT; Danish Breast Cancer Cooperative Group. Christiansen P, et al. J Natl Cancer Inst. 2011 Sep 21;103(18):1363-72. doi: 10.1093/jnci/djr299. Epub 2011 Aug 31. J Natl Cancer Inst. 2011. PMID: 21881042
69 results
Jump to page
Feedback